Drug intelligence / Profile preview

Haleigh's Hope

Development stage
Unknown
Lead developer
Haleigh's Hope
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Inhalation
01

Overview

Haleigh's Hope is a proprietary, high-cannabidiol (CBD), low-tetrahydrocannabinol (THC) medical cannabis strain and whole-plant hemp extract. It was specifically bred by Jason Cranford and developed by the Flowering H.O.P.E. Foundation for its therapeutic properties, particularly its anticonvulsant effects. Named after Haleigh Cox, a child whose severe epilepsy and cerebral palsy symptoms were significantly alleviated by the oil derived from this strain, Haleigh's Hope typically features a CBD:THC ratio of 24:1 or higher (e.g., 30:1, 20:1), ensuring non-psychoactive effects. It is made from organic, non-GMO ingredients and is legally classified as a hemp product in the United States due to its THC content being below 0.3%. It is utilized in medical cannabis programs for various conditions.

Brand names
Haleigh's Hope
Other names
Haleigh's Hope
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Haleigh's Hope.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haleigh's Hope.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call